Sally Ellis, Neonatal Sepsis Project Leader, GARDP
Sally Ellis joined GARDP in January 2017 (and rejoined DNDi) as the Project Leader of the Neonatal Sepsis Programme, she is responsible for the management of clinical activities aimed at developing 1-2 new treatments for life threatening neonatal infections.
She has experience working as a clinical and project manager in the pharmaceutical industry (including Hoffman-La Roche and Smith Kline & Beecham), CROs, as well as the not-for-profit sector (PDP and academica). She is also a highly experienced clinical trialist. This has included 7 years at DNDi where she was instrumental in building and coordinating DNDi’s clinical portfolio in Visceral Leishmaniasis. Most recently she worked in the Royal Marsden in the UK as the CTU Operations Manager where she had the remit to establish the clinical trial unit for all investigator led trials.
Sally has significant experience working in resource limited settings and also has a Masters in Global Health Policy from the LSH&TM (2015).